Class Of Stock [Axis]
Series H Convertible Preferred Stock
Series I Convertible Preferred Stock
Business Acquisition [Axis]
Veneto Holdings, L.L.C.
Regentys
Olaregen
Medisource
Pantheon [Member]
Legal Entity [Axis]
Hema Diagnostic Systems, LLC
Option Indexed to Issuer's Equity, Type [Axis]
Call Option
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Liability Class [Axis]
Derivative liability
Warrants
Property, Plant and Equipment, Type [Axis]
Computers and technological assets [Member]
Machinery and Equipment [Member]
Furniture and Fixtures [Member]
Indefinite-lived Intangible Assets [Axis]
Empire State Pharmacy
Grainland Pharmacy assets
Related Party [Axis]
Berkman
Alternative Execution Group [Member]
Litigation Case [Axis]
Damages for Unpaid Invoices
Breach of contract and detinue
Computers and technological assets
Leasehold Improvements [Member]
Grainland Pharmacies Holdings
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Stock Purchase Agreement
NGDx
Olaregen Series A Preferred Stock [Member]
Regentys Series A Redeemable Convertible Preferred Stock [Member]
B-H Sanford, LLC
Salvo
Moscato
Stock Conversion Description [Axis]
Remain To Be Issued
Post Reverse Stock Split
Net Purchase Price
After Closing
At Closing
Financial Instrument [Axis]
Principal
Long-term Debt, Type [Axis]
Notes Payable
Accrued Interest
Range [Axis]
Minimum [Member]
Maximum [Member]
Generex Pharmaceuticals
Antigen Express
Antidilutive Securities [Axis]
Series H Convertible Preferred Stock
Series I Convertible Preferred Stock
Convertible Debt
Stock options
Finite-Lived Intangible Assets by Major Class [Axis]
In Process Research and Development [Member]
Noncompete Agreements [Member]
Developed Software/Technology [Member]
Vendor agreements and other intangibles [Member]
Other Intangible Assets [Member]
Warrant
Allocation Adjustments
Final Allocation
"Veneto First Closing"
"Veneto Second Closing"
Total
Total
Preliminary Fair Value
Referral Base [Member]
Tradename / Trademarks [Member]
IP/Technology [Member]
Business Contracts [Member]
Customer Base [Member]
Revised Allocation
Preliminary Allocations
Grainland Pharmacy Holdings
Empire State Pharmacy Holdings
Derivative Liability Convertible Notes
Derivative Liability Warrants
Derivative Liability Downside Protection
Investors
AEXG
Former Shareholder
Plan Name [Axis]
Stock Option Plan 2006
Stock Option Plan 2017
Stock Options
Stock Option Plan 2019
Subsequent Event Type [Axis]
Subsequent Event [Member]
Interest
MediSource Partners [Member]
Public Secured Financing Facility Agreement [Member]
Securities Purchase Agreement
Share Exchange Agreement
ALTuCELL [Member]
Equity Purchase Agreement
Equity Components [Axis]
Preferred Stock
Common Stock
Common Stock Payable
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Sub Total
Noncontrolling Interest
Goodwill
Document And Entity Information
Entity Registrant Name
Entity Central Index Key
Entity Filer Category
Entity Incorporation, State or Country Code
Entity Small Business
Entity Emerging Growth Company
Document Type
Amendment Flag
Statement [Table]
Statement [Line Items]
Class of Stock [Axis]
ASSETS
Current Assets
Cash and cash equivalents
Accounts receivable, net
Inventory, net
Other current assets
Total Current Assets
Property and equipment
Call option
Goodwill
Intangible assets
Operating lease right-of-use assets - net
Other assets, net
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
Current Liabilities
Accounts payable and accrued expenses
Notes payable, current
Loans from related parties
Operating lease liabilities - net of current portion
Deferred tax liability
Total Current Liabilities
Derivative liability
Common stock payable
Warrants to be issued
Total Liabilities
Redeemable non-controlling interest
Stockholders' Equity (Deficiency)
Convertible Preferred Stock
Common stock
Common stock payable
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Non-controlling interest
Total Stockholders' Equity (Deficiency)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)
Convertible preferred stock, par value (in dollars per share)
Convertible preferred stock, shares authorized
Convertible preferred stock, shares issued
Common stock, par value (in dollars per share)
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenue
Revenue, net
Licensing income
Total Revenue
Cost of Goods Sold
Gross Profit
Operating expenses
Research and development
Bad debt expense
General and administrative
Total operating expenses
Operating loss
Other Income (Expense):
Interest expense
Interest income
Changes in fair value of contingent purchase consideration
Change in fair value of derivative liability
Gain on extinguishment of debt
Impairment of long-lived assets
Other income, net
Net (Loss) Income
Net loss attributable to non-controlling interests
Net Income (Loss) Available to Common Stockholders
Net Income (Loss) per Common Share
Basic
Diluted
Shares Used to Compute Income per Share
Basic
Diluted
Comprehensive Income :
Net Income (Loss)
Change in foreign currency translation adjustments
Comprehensive Income Available to Common Stockholders
Balance
Balance (in shares)
Investment in subsidiary by noncontrolling interest
Conversion of preferred series H
Conversion of preferred series H (in shares)
Conversion of preferred series I
Conversion of preferred series I (in shares)
Exercise of call option to acquire noncontrolling interest
Stock compensation expense
Issuance of common stock payable
Issuance of common stock payable (in shares)
Conversion of debt to equity
Conversion of debt to equity (in shares)
Issuance of stock options
Issuance of common stock for conversion of debt
Issuance of common stock for conversion of debt (in shares)
Antigen dividend
Issuance of warrants
Acquisition of NCI of Regentys
Acquisition of NCI of Olaregen
Acquisition of Olaregen Series A Preferred Stock
Reclassification of equity to liability
Extinguishment of derivative liability associated with convertible notes
Issuance of common stock for acquisitions
Issuance of common stock for acquisitions (in shares)
Reduction of derivative liabilities
Cancellation of shares
Cancellation of shares (in shares)
Purchase of shares in subsidiary
Currency translation adjustment
Net Income (loss)
Balance
Balance (in shares)
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization
Impairment of long-lived assets
Impairment of goodwill
Amortization of operating lease right-of-use assets
Stock compensation expense
Loss on extinguishment of debt
Changes in fair value of contingent purchase consideration
Amortization of debt discount
Non-cash interest expense from issuance on debt (derivative)
Change in fair value of derivative liabilities - convertible notes
Change in fair value of derivative liabilities - convertible warrants
Change in fair value of derivative liabilities - downside protection
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable
Inventory
Accounts payable and accrued expenses
Accrued interest on notes receivable
Loans from related parties
Other current assets
Other current liabilities
Other assets, net
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Purchase of intangible assets
Disposal of property and equipment
Disposal of intangible assets
Cash received in acquisition of a business, net of cash paid
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Loan proceeds from related party
Payment of notes payable
Proceeds from note payable
Investment in subsidiary by noncontrolling interest
Net cash provided by financing activities
Effects of currency translation on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental Disclosure of Cash Flow Information
Antigen dividend
Conversion of HDS debt and issuance of call option
Conversion of debt to equity
Exercise of call option
Acquisition of Olaregen stock through issuance of common stock
Acquisition of Veneto through issuance of debt
Acquisition of Regentys through issuance of debt
Acquisition of Olaregen through issuance of debt
Reduction of derivative liabilities
Discount on derivative liability upon issuance of debt
Issuance of common stock for conversion of debt
Recording of Right of Use Asset and Liability
Increase common stock payable
Issuance of shares-common stock payable
Note payable issued for acquisition of a business
Accounting Policies [Abstract]
Organization of Business and Going Concern
Summary of Significant Accounting Policies
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]
Loans from Related Parties
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Leases [Abstract]
Leases
Property, Plant and Equipment [Abstract]
Property and Equipment
Equity [Abstract]
Stockholders' Equity
Notes to Financial Statements
Redeemable Non-Controlling Interest
Inventory Disclosure [Abstract]
Inventory
Debt Disclosure [Abstract]
Notes Payable
Income Tax Disclosure [Abstract]
Income Taxes
Net Income Per Share (EPS)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets
Business Combinations [Abstract]
Acquisitions
Derivative Liability
Warrants
Warrants
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation
Business Combinations
Cash and Cash Equivalents
Patents
Revenue Recognition
Intangible Assets
Impairment or Disposal of Long-Lived Assets and Intangibles
Derivative Liability
Research and Development Costs
Income Taxes
Inventories
Property and Equipment
Goodwill
Stock-Based Compensation
Net Income (Loss) per Common Share
Comprehensive Income/(Loss)
Foreign Currency Transactions and Translations
Fair Value of Financial Instruments
Use of Estimates
Redeemable Non-Controlling Interest
Derivative Financial Instruments
Adoption of New Accounting Standards
Recently Issued Accounting Standards
Fair Value, Liabilities Measured on Recurring Basis
Schedule of Future Minimum Rental Payments for Operating Leases
Property and Equipment
Schedule of Inventory
Deferred income taxes
Reconciliation of effective tax rate
Computation of diluted EPS
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Schedule of Intangible Assets
Estimated amortization expense
Changes in value of goodwill
Net purchase price of NGDx
Fair Value Assumptions Used in Accounting for Warrants
Fair Value Assumptions Used in Accounting for Call Options
Purchase price allocated as of acquisition date
Summary of Acquisition
Estimated amortization expense
Schedule of Finite-Lived Intangible Assets
Summary of allocation of preliminary purchase price
Components of acquired intangible assets
Supplemental Pro Forma
Schedule of Derivative Liabilities at Fair Value
Schedule of warrant activities
Common stock options granted, forfeited or expired and exercised
Fair value assumptions used in Black-Scholes option-pricing
Majority interest
Working capital deficiency
Secured promissory note Description
Derivative liability
Total
Estimated useful lives
Liability
Asset impairment charge
Write down of inventory
Decrease in deferred tax assets
Federal income tax rate
Interest rate
Outstanding balance
Accrued interest
Agreement terms
Loans payable to related parties
Repayment of loan
Proceeds from Loans
Accounts receivable
Value of damages sought
Counterclaim proceeding
Lawsuit filing date
Name of Plaintiff
Settlement of litigation
Interest per annum, failure to pay settlement
Fixed cost per annum, failure to pay settlement
Commitments and Contingencies
Rental Payment, 2020
Rental payment, 2021
Litigation awards for damages
Litigation awards, exercisable shares
Exercise price
Memorandum of Understanding description
Note amount
Intellectual property acquired
Value of the warrants
Liquidated damages
Accrued Liquidated damages
Accrued claim
2019
2020
2021
2022
2023
Thereafter
Total undiscounted operating lease payments
Less: Imputed interest
Present value of operating lease liabilities
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average discount rate
Operating lease expense
Property and equipment
Less accumulated depreciation
Property and equipment, net
Depreciation expense
Disposal of assets
Impairment of long-lived assets
Common stock issued
Acquisition in HDS
Shares of common stock, obligated to issue
Common stock purchase warrants, exercise price
Common stock issued upon conversion of preferred stock
Converted stock amount, payment to holder
Common stock issued as "make-whole payments" on conversions of preferred stock
Common stock payable, Shares
Common stock payable, Amount
Warrants exercised, shares
Convertible preferred stock shares issued value
Net (loss) attributable to noncontrolling interests
LOI Terms
Common stock issued for acquisition
Notes payable for acquisition
Number of Preferred Stock
Common stock issued for conversion debt, Shares
Common stock issued for conversion debt, Value
Stock issued for conversion of note payable, Shares
Stock issued for conversion of note payable, Value
Fair value
Stock Price
Cancellation of common stock
Preferred stock, shares outstanding
Non-controlling interest
Percentage of non-controlling interest
Redeemable Non-Controlling Int
Raw materials
Finished goods
Total Inventory
Statistical Measurement [Axis]
Purchase price of note
Investor fee
Original issue discount
Effective interest
Interest rate
Due date
Common stock issued in satisfaction notes
Number of warrants sold
Payment of Promissory Note
Accrued interest
Derivative liability
Amortization of debt discount
Debt discount
Number of common stock converted
Deferred tax liability
Notes payable
Loss on settlement of debt
Settlement of debt
Net operating loss carryforwards
Other temporary differences
Intangible assets
Total Deferred Tax Assets
Valuation Allowance
Deferred Tax Liabilities
Intangible assets
Other temporary differences
Total Deferred Tax Liabilities
Net Deferred Income Taxes
Federal statutory rate
Increase (decrease) in income taxes resulting from:
Change in fair value of purchase consideration
Expiration of net operating loss carryforward
Other
Tax rate change
Change in valuation allowance
Effective tax rate
Pre-tax gain or (loss) arising from domestic operations
Pre-tax (losses) arising from foreign operations
NOL carryforwards
Weighted average number of common shares outstanding - Basic
Potentially dilutive common stock equivalents
Weighted average number of common and equivalent shares outstanding-Diluted
Total
Intangible assets gross
Less accumulated amortization
Intangible assets net
2020
2021
2022
2023
2024
Thereafter
Total
Balance at beginning
Acquisition
Balance at end
Amortization expense
Purchase price:
Stock Price at Closing
Shares
Fair Value
Exercise price
Time to expiration
Risk-free interest rate
Estimated volatility
Dividend
Stock price at period end date
Remaining Term
Stock price at valuation date
Intangible assets
Property and Equipment
Computer software acquired
Leasehold Improvements
Total Assets Acquired
Consideration:
Note Payable
Prepaid expenses
Other receivables
Notes receivable - LT
Intangible assets, net
Total assets acquired
Total current liabilities
Notes payable
Total liabilities assumed
Net identifiable assets acquired
Total consideration transferred
Accounts payable and accrued liabilities
Net Tangible Assets
Tradename / Trademarks
Business Contracts
Non-Competes
Total Fair Value of Assets Acquired
Fair value of common stock
Contingent consideration
Consideration included in consulting agreement
Total Purchase Price
Prepaid Expenses
Inventory
Medical Equipment, net
Accounts payable
Accrued liabilities
IP/Technology
Non-compete agreement
Customer Base
Total assets acquired
Total
Average Estimated Life
Notes payable
Loans from related parties
Deferred tax liability
In-process research & development
Note receivable from Generex
Cash paid prior to the time of closing
Cash paid prior to the time of closing
Note receivable from Generex
Revenues
Cost of revenues
Gross profit
Operating expenses
Operating loss
Other income (expense)
Net loss
Net loss attributable to noncontrolling interests
Net Income (loss) Available to Common Stockholders
Comprehensive net loss
Basic and diluted earnings per share
Acquisition of interest
Acquisition of outstanding limited liability company units
Value of shares exchanged for outstanding limited liability units
Limited liability company units receied
Call Option
Call option recorded as an asset
Changes in fair value of contingent purchase consideration
Warrant issued to acquire stock
Common stock, price per year
Total consideration
Intangible assets acquired
Aggregate purchase price
Shares exercisable
Promissory Note
Promissory Note, Due Date
Promissory Note, interest rate
Goodwill impairment
Business combination description
LOI description
Derivative liabilities at beginning
Additions during the period
Change in fair value
Change due to exercise / redemptions
Derivative liabilities at end
Number of Warrants Outstanding at beginning
Number of Warrants issued
Number of Warrants Forfeited
Number of Warrants Outstanding at end
Weighted Average Exercise Price per Share Outstanding at beginning
Weighted Average Exercise Price per Share issued
Weighted Average Exercise Price per Share Forfeited
Weighted Average Exercise Price per Share Outstanding at end
Weighted Average Remaining Life of Warrants Outstanding at beginning (Years)
Weighted Average Remaining Life of Warrants issued (Years)
Weighted Average Remaining Life of Warrants Outstanding at end (Years)
Aggregate Intrinsic Value Warrants Outstanding at beginning
Aggregate Intrinsic Value Warrants issued
Aggregate Intrinsic Value Warrants Forfeited
Aggregate Intrinsic Value Warrants Outstanding at end
Number of warrants forfeited
Options Outstanding, Beginning
Options Granted
Options Forfeited or expired
Options Exercised
Options Outstanding, End
Weighted Average Exercise Price per Share, Beginning
Weighted Average Exercise Price per Share, Granted
Weighted Average Exercise Price per Share, Forfeited or expired
Weighted Average Exercise Price per Share, Exercised
Weighted Average Exercise Price per Share, End
Weighted Average Remaining Life Options Outstanding (Years)
Weighted Average Remaining Life Options Granted
Weighted Average Remaining Life Options Forfeited or expired
Aggregate Intrinsic Value Options, Outstanding Beginning
Aggregate Intrinsic Value Options Granted
Aggregate Intrinsic Value Options, Outstanding Ending
Expected term
Expected dividend
Common stock reserved for future issuance
Common stock reserved for future awards
Market value
Options vested
Compensation expense
Unrecognized compensation costs
Unrecognized compensation period
Repayment of loan
Financial advisory services description
Financing Facility
Note description
Number of shares increased
Letter of Intent description
Number of shares cancelled
Consulting services description
Performance incentive decription
Number of Preferred stock converted
Common stock description
Stock Purchase Agreement description
Damages For Unpaid Invoices [Member]
Breach Of Contract [Member]
Percentage of interest expense directly attributable to an award in settlement of litigation.
Stock Option Plan 2006 [Member]
SeriesHConvertiblePreferredStockMember
SeriesIConvertiblePreferredStockMember
Total1Member
Assets, Current
CallOptions
Goodwill [Default Label]
Assets
Derivative Liability, Noncurrent
Liabilities
Common stock payable [Default Label]
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Interest Expense
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Diluted
Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax
Shares, Outstanding
Other Asset Impairment Charges
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Increase (Decrease) in Accrued Interest Receivable, Net
Increase (Decrease) in Due to Related Parties
Increase (Decrease) in Other Operating Assets and Liabilities, Net
Increase (Decrease) in Other Operating Assets
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Intangible Assets
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Gain (Loss) on Disposition of Intangible Assets
Net Cash Provided by (Used in) Investing Activities
Repayments of Notes Payable
Investment in subsidiary by noncontrolling interest [Default Label]
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Licensing income [Default Label]
ConversionOfDebtsToEquity
ReductionOfDerivativeLiabilities
IssuanceOfCommonStockForConversionOfDebt
Debt Disclosure [Text Block]
WarrantsTextBlock
Derivatives, Policy [Policy Text Block]
Income Tax, Policy [Policy Text Block]
Property, Plant and Equipment, Policy [Policy Text Block]
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Share-based Payment Arrangement [Policy Text Block]
Earnings Per Share, Policy [Policy Text Block]
RedeemableNoncontrollingInterestPoliciesTextBlock
Property, Plant and Equipment [Table Text Block]
Estimated amortization expense [Default Label]
Derivative Liability, Current
Total [Default Label]
Other Commitments, Description
Operating Leases, Future Minimum Payments Due
ImputedInterest
Operating Lease, Liability
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Moscato [Default Label]
NoncontrollingInterest
Debt Instrument, Interest Rate During Period
Debt Instrument, Increase, Accrued Interest
Derivative Liability, Fair Value, Gross Liability
Amortization of Debt Issuance Costs and Discounts
Deferred Tax Liabilities, Net
Intangible Assets, Current
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Liabilities, Intangible Assets
Deferred Tax Liabilities, Other
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Finite-Lived Intangible Assets, Amortization Expense, Year Three
Finite-Lived Intangible Assets, Amortization Expense, Year Four
Finite-Lived Intangible Assets, Amortization Expense, after Year Five
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
Property and Equipment [Default Label]
Accounts Payable, Current
Accrued Liabilities, Current
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles
Due from Related Parties, Current
Cash paid prior to the time of closing [Default Label]
Note receivable from Generex [Default Label]
BusinessAcquisitionsProFormaOperatingExpenses
CallOption
ChangesInFairValueOfContingentPurchaseConsiderations
Derivative Liability [Default Label]
Class of Warrant or Right, Outstanding
AggregateIntrinsicValueWarrantsOutstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Repayments of Long-term Debt